The Neurosurgical Oncology ward 7

 Neurosurgical Oncology ward 7 (endoscopic cranial base surgery and intracranial and extracranial communicated tumor center) is a diagnosis and treatment center with both microscopic transcranial and endoscopic transnasal/oral surgical treatment of complex cranial base diseases. The annual operation volume is more than 1100 sets, and the number and curative effect have reached the domestic leading and international first-class level. The center, led by Professor Pinan, Liu，focuses on the clinical treatment and basic research of neuroendoscopy in the cranial base lesions, the research of new technologies in the basic and clinical treatment of neurofibromatosis, the research of cognitive function in central nervous system lesions and the reconstruction of neural function. The department consists of neurosurgeons, neurooncologists and neuropsychologists, as well as clinical researchers and nursing staff. At present, there are 3 chief physicians, 7 deputy chief physicians/associate professors, 1 doctoral supervisor, 3 master supervisors, 37 beds and 2 clinical trial beds. Treatment of diseases including various parts of the intracranial tumors, especially the skull base and intracranial and extracranial communicatied tumors, such as pituitary tumors, craniopharyngioma, chordoma, chondroma, pterygopalatine fossa and cavernous sinus tumors, cerebrospinal fluid leakage and other surgical treatment. The scope of diagnosis and treatment covers complex lesions such as acoustic neuroma, olfactory neuroblastoma, orbital/ petrosus meningioma, jugular foramen and magnum tumors,

   The Center has undertaken 11 national/provincial and ministerial scientific research projects, and is currently researching 1 international multi-center clinical drug trial and taking the lead in 1 domestic multi-center clinical trial. We participated in the compilation of more than 10 textbooks works such as "Anatomical Atlas of ventral skull Base Endoscopy", and led the formulation of "Pituitary tumor therapy Standard 2023 edition", which won Two Beijing Science and Technology Progress Awards. The project "Neuroendoscopy Minimally Invasive Treatment of skull base Lesions" won the second prize of Science and Technology Progress of the Ministry of Education in 2010. We established the first comprehensive diagnosis and treatment center for neurofibromatosis in China, and won the second prize of the 2022 Huaxia Medical Science and Technology Award for "Establishment and application of Type 2 neurofibromatosis clinical diagnosis and treatment system".

    Based on the advantages of diagnosis and treatment technology, the department continues to develop and innovate, always taking the patient as the center, and constantly improving clinical managment and research levels to better serve patients as well as the society.

Introduction of discipline leader

Pinan Liu   Director of t Neurosurgical Oncology ward 7, Director of Neuro-Reconstruction department of Beijing Institute of Neurosurgery, Chinese Academy of Medical Sciences, Chief physician, professor, Doctoral supervisor, the discipline leader of Beijing Health System. He is the deputy chairman of Neuroendoscopy Committee of Neurosurgery Branch of Chinese Medical Doctor Association, the chairman of Neurosurgery Branch of China Association for the Promotion of International Medical Care Exchange, and the deputy chairman of Neuropsychology Branch of Chinese Psychological Society. He has studied under Professor Han Demin, a famous expert in otolaryngology and head and neck surgery, academician of the Chinese Academy of Engineering, and Professor Wang Zhongcheng, a famous expert in neurosurgery and academician of the Chinese Academy of Engineering. He has been engaged in clinical work of neurosurgery for a long time, and has completed more than 9,000 cases of various neurosurgery operations, especially in the surgical treatment of intracranial and extracranial communicated tumors and skull base reconstruction technology, and endoscopic nasal surgery for skull base lesions. He has completed more than 4,000 cases of neuroendoscopic resection of tumors in the skull base/intracranial midline and repair of cerebrospinal fluid leakage. He has presided over and completed 7 national/provincial and ministerial scientific research projects such as the "12th Five-Year" National Science and Technology Support Plan and the National Natural Science Foundation, and published more than 60 papers in high-level SCI journals such as PNAS and Neuro-oncology.

Weiqing Wan  chief physician, MD, associate professor, and master's supervisor, is proficient in the diagnosis and surgical treatment of intracranial tumors, including pituitary adenoma, auditory neuroma, posterior cranial fossa, skull base tumor, and glioma. He is a member of the Standing Committee of the Molecular Tumor and Immunotherapy Committee of the Chinese Society of Research Hospitals. He has presided over and participated in many national research projects, including the National Natural Science Program and international collaborative projects. He has been awarded as an advanced individual in the "Three Rural Areas" of culture, science, technology, and health and an excellent communist member of the Beijing Municipal Health Planning Commission.

Xingchao Wang  Deputy director of Neurosurgical Oncology ward 7, Doctor of Medicine, Associate Chief physician, Associate professor, Master's research supervisor. Visiting scholar of Department of Neuroscience and Neurosurgery, Icahn School of Medicine at Mount Sinai, USA. National member and deputy Secretary-General of Neurosurgery Branch of China Association for Promotion of International Exchanges in Healthcare, Secretary of Neuropsychology Branch of Chinese Psychological Society. He is good at minimally invasive surgical treatment of brain tumors, including diagnosis and treatment of pituitary tumor, meningioma, glioma, schwannoma and other diseases, especially neuroendoscopic minimally invasive surgical treatment of skull base tumors. At the same time, he focuses on advanced brain cognitive functions related to neurosurgical diseases, and has organized and carried out major national/provincial and ministerial scientific research projects such as overseas research projects of the National Natural Science Foundation for Hong Kong, Macao and Taiwan cooperation projects, and research projects of the Beijing Brain Program. He presided over the research projects of the National Natural Science Foundation and the Capital Health Development Research Fund, and was selected into the "Green Seedling" talent training plan of Beijing Municipal Hospital Administration. He has published 34 SCI papers in Brain, eLife, Journal of Neuroscience and other famous neuroscience journals.

The Neurosurgical Oncology ward 7 Neurosurgical Oncology ward 7 (endoscopic cranial base surgery and intracranial and extracranial communicated tumor center) is a diagnosis and treatment center with both microscopic transcranial and endoscopic transnasal/oral surgical treatment of complex cranial base diseases. The annual operation volume is more than 1100 sets, and the number and curative effect …